Selskabets formål er forskning, udvikling og kommercialisering af medicinske produkter samt aktiviteter, der efter ledelsens skøn er forbundet dermed.
CVR: 44960907
registered with 25% ownership
Jonathan David McNeill joined the board
Emmanuelle Coutanceau joined the board
Gabor Gyulveszi joined the board
Lloyd Berl Klickstein joined the board
Marie Allen Schroeder left the board
Emmanuelle Coutanceau left the board
Thomas Gundelund Rasmussen joined as ADM. DIR.
Søren Sylvester Skjærbæk left as ADM. DIR.
Alexander James Colville joined the board
Companies in the same industry and area
CVR 40766383
CVR 34688605
CVR 44504332
CVR 43917897
CVR 41997907